Introduction
============

Anonaine (**A**, [Figure 1](#molecules-13-00475-f001){ref-type="fig"}) is an aporphine isoquinoline alkaloid isolated from the plant species *Magnolia ovobata* Thun. (Magnoliaceae). Anonaine shows antiperoxidative \[[@B1-molecules-13-00475]\], antibacterial and anti-fungal activities \[[@B2-molecules-13-00475]\]. Anonaine also displays intense dopamine-uptake inhibitory properties, which can lead to a potential anti-depressant activity \[[@B3-molecules-13-00475]\].

![Chemical structures of anonaine (**A**) and liriodenine (**B**).](molecules-13-00475-g001){#molecules-13-00475-f001}

In dopamine biosynthetic pathways, tyrosine hydroxylase (TH, EC 1.14.16.2), which is the first and rate-limiting enzyme, catalyzes the conversion of [l]{.smallcaps}-tyrosine to [l]{.smallcaps}-3,4-dihydroxyphenylalanine ([l]{.smallcaps}-DOPA) and [l]{.smallcaps}-DOPA is then converted to dopamine by aromatic [l]{.smallcaps}-amino acid decarboxylase (AADC, EC 4.1.1.28). Intracellular cyclic AMP level and Ca^2+^ concentration are known to regulate TH activity and TH gene expression via protein kinase A (PKA), protein kinase C (PKC) and Ca^2+^/calmodulin kinase II in PC12 cells \[[@B4-molecules-13-00475],[@B5-molecules-13-00475]\]. AADC is also modulated in the central nervous system as is TH \[[@B6-molecules-13-00475]\]. [l]{.smallcaps}-DOPA is the most frequently prescribed drug for controlling the symptoms of Parkinson's disease \[[@B7-molecules-13-00475]\], but it has been found to accelerate deterioration of Parkinson patients\' condition after long-term treatment \[[@B8-molecules-13-00475]\] and can induce cytotoxicity in neuronal and PC12 cells \[[@B8-molecules-13-00475],[@B9-molecules-13-00475]\].

Aporphine alkaloids such as bulbocapnine and liriodenine (**B**, [Figure 1](#molecules-13-00475-f001){ref-type="fig"}) showed inhibitory effects on dopamine biosynthesis in PC12 cells \[[@B10-molecules-13-00475],[@B11-molecules-13-00475]\]. In addition, boldine, glaucine and some halogenated boldine derivatives, which are also based on the aporphine skeleton, appear to exhibit anti-oxidant properties \[[@B12-molecules-13-00475]\] and brain anti-dopaminergic activities \[[@B13-molecules-13-00475],[@B14-molecules-13-00475]\]. However, the dopamine-related pharmacological functions on anonaine are poorly understood. PC12 rat adrenal pheochromocytoma cell lines have dopamine synthesizing, storing and releasing properties, similar to those of neurons \[[@B15-molecules-13-00475]\]. PC12 cells also express the catecholamine biosynthetic enzymes such as TH, AADC and dopamine β-hydroxylase (EC 4.14.17.1) \[[@B15-molecules-13-00475],[@B16-molecules-13-00475]\]. In the present study, therefore, the inhibitory effects of anonaine on dopamine biosynthesis and [l]{.smallcaps}-DOPA-induced cytotoxicity in PC12 cells were examined.

Results and Discussion
======================

Intracellular dopamine content
------------------------------

Anonaine at concentration ranges of 0.01-0.2 μM reduced the intracellular dopamine content of PC12 cells in a concentration-dependent manner after 24 h exposure (57.8% inhibition at 0.06 μM). The IC~50~ value of anonaine was 0.05 μM ([Table 1](#molecules-13-00475-t001){ref-type="table"}). Anonaine at concentrations up to 0.5 μM were not cytotoxic and did not change the cell morphology for 48 h towards PC12 cells. However, at concentrations higher than 1 μM, anonaine caused a severe cytotoxicity for 48 h, as determined by MTT assay. Therefore, 0.05 μM anonaine was used in subsequent experiments.

molecules-13-00475-t001_Table 1

###### 

Inhibitory effects of anonaine on dopamine content in PC12 cells. PC12 cells were treated with anonaine for 24 h. The cells were harvested with phosphate buffered saline and dopamine content was measured by an HPLC method. The control value of dopamine content was 3.70 ± 0.23 nmol/mg protein. Results represent means ± S.E.M of 6-8 dishes. \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001 compared to control levels (ANOVA followed by Tukey's test).

             Dopamine content (nmol/mg protein)   (% of control) IC~50~ value
  ---------- ------------------------------------ -----------------------------
  Control    3.70 ± 0.23                          \(100\)
  Anonaine                                           0.05 μM
   0.01 μM   3.05 ± 0.26                          (82.4)
   0.03 μM   2.55± 0.17                           (68.9)^\*^
   0.06 μM   1.56 ± 0.19                          (42.2)^\*\*^
   0.08 μM   0.94 ± 0.15                          (25.4)^\*\*\*^

Dopamine content began to decrease at 1 h and reached minimal levels (about 37.7% of control levels) at 12 h after exposure to 0.05 μM anonaine ([Figure 2](#molecules-13-00475-f002){ref-type="fig"}A). The decreased dopamine levels started to recover at 24 h and then reached the control levels at 72 h. The dopamine content in the medium, which was secreted from intracellular dopamine stores in PC12 cells, was increased to 472% compared to control levels at 30 min by treatment of 0.05 μM anonaine ([Figure 2](#molecules-13-00475-f002){ref-type="fig"}B). However, the extracellular dopamine content did not increase after 3 h.

![Time courses of intracellular (A) and extracellular (B) dopamine content by anonaine (0.05 µM) in PC12 cells. The intracellular and extracellular dopamine content of control levels were 3.78 ± 0.26 and 0.15 ± 0.05 nmol/mg protein, respectively. Results represent means ± S.E.M. of 6-8 dishes. Significantly different from control values: \*\*\*P\<0.001 (ANOVA followed by Tukey's test).](molecules-13-00475-g002){#molecules-13-00475-f002}

TH and AADC activities
----------------------

TH activity was inhibited by 0.05 μM anonaine to 38.4-61.2% of control levels at 12-48 h and recovered to 88.5% of control at 72 h ([Figure 3](#molecules-13-00475-f003){ref-type="fig"}A). AADC activity was also inhibited to 78.4% of control levels at 3 h and then recovered rapidly to control levels at about 6-12 h with 0.05 μM anonaine ([Figure 3](#molecules-13-00475-f003){ref-type="fig"}B). TH activity was more markedly inhibited by anonaine for a longer period than AADC activity.

![Time courses of TH (A) and AADC (B) activities by anonaine (0.05 µM) in PC12 cells. The control values of the activities of TH and AADC were 3.68 ± 0.29 and 32.5 ± 3.51 nmol/min/mg protein. Results represent means ± S.E.M. of 6-8 dishes. Significantly different from control values: \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001 (ANOVA followed by Tukey's test).](molecules-13-00475-g003){#molecules-13-00475-f003}

TH mRNA and cyclic AMP levels, and Ca^2+^ concentration
-------------------------------------------------------

TH mRNA levels were slightly decreased at about 6-24 h after exposure to 0.05 μM anonaine: the decreased intensity was weak ([Figure 4](#molecules-13-00475-f004){ref-type="fig"}). In addition, anonaine at 0.05 μM significantly decreased intracellular cyclic AMP levels to 40.1-41.3% of control levels at 10 and 60 min ([Figure 5](#molecules-13-00475-f005){ref-type="fig"}A). However, intracellular Ca^2+^ concentration was not reduced by 0.05 μM anonaine ([Figure 5](#molecules-13-00475-f005){ref-type="fig"}B).

![Effects of anonaine on TH mRNA levels in PC12 cells. RNA was extracted and 10 µg aliquots were subjected to electrophoresis on formaldehyde gels, blotted onto nylon membrane and probed with ^32^P-labeled cDNA probes for rat TH and α-tubulin. Equal loading of the gels was verified by ethidium bromide staining of total RNA. Relative densitometry ratio in control was expressed as 1 arbitrary unit (means ± S.E.M., n=3). Significantly different from control values: \*P\<0.05 (ANOVA followed by Tukey's test).](molecules-13-00475-g004){#molecules-13-00475-f004}

[l]{.smallcaps}-DOPA-induced dopamine biosynthesis and cytotoxicity
-------------------------------------------------------------------

[l]{.smallcaps}-DOPA at 50 μM and 100 μM for 24 h increased intracellular dopamine content to 253% and 280%, respectively, compared to untreated control in PC12 cells ([Figure 6](#molecules-13-00475-f006){ref-type="fig"}A) \[[@B17-molecules-13-00475]\]. When 50-100 μM [l]{.smallcaps}-DOPA was associated with 0.05 μM anonaine, the intracellular dopamine content was significantly decreased by 98.2% and 105%, compared to [l]{.smallcaps}-DOPA alone ([Figure 6](#molecules-13-00475-f006){ref-type="fig"}A). Similar patterns were also observed after 48 h of incubation (data not shown). In addition, 50 μM and 100 μM [l]{.smallcaps}-DOPA for 24 h reduced cell viability to 90.8% and 79.5% of control levels ([Figure 6](#molecules-13-00475-f006){ref-type="fig"}B) \[[@B17-molecules-13-00475]\]. However, when 50 μM and 100 μM [l]{.smallcaps}-DOPA were associated with 0.05 μM anonaine for 24 h, the cell viability showed moderate increases of 6.1% and 6.0%, compared to [l]{.smallcaps}-DOPA alone ([Figure 6](#molecules-13-00475-f006){ref-type="fig"}B). Co-treatments with 20 μM and 50 μM [l]{.smallcaps}-DOPA plus 0.05 μM anonaine for 48 h resulted in about 10.0% and 7.7% increases of cell viability from 83.1% and 71.2%, respectively, compared to the corresponding concentrations of [l]{.smallcaps}-DOPA alone (data not shown).

Isoquinoline alkaloids such as higenamine, berberine, palmatine, ethaverine, hydrastine and tetrahydropapaveroline were found to regulate dopamine biosynthesis by reducing TH activity in PC12 cells \[[@B18-molecules-13-00475],[@B19-molecules-13-00475],[@B20-molecules-13-00475],[@B21-molecules-13-00475],[@B22-molecules-13-00475]\]. Aporphine alkaloids such as bulbocapnine and liriodenine also reduced dopamine content in PC12 cells \[[@B10-molecules-13-00475],[@B11-molecules-13-00475]\]. In addition, tetrahydropapaveroline, berberine, palmatine, hydrastine and bulbocapnine inhibited TH activity, which was prepared from bovine adrenal gland \[[@B22-molecules-13-00475],[@B23-molecules-13-00475],[@B24-molecules-13-00475],[@B25-molecules-13-00475]\]. Dopamine biosynthesis was regulated by TH and AADC activities \[[@B6-molecules-13-00475],[@B26-molecules-13-00475]\], which were activated by cyclic AMP and Ca^2+^ concentrations mediated by PKA, PKC and Ca^2+^/calmodulin kinase \[[@B4-molecules-13-00475],[@B5-molecules-13-00475]\]. In this study, anonaine at 0.05 μM decreased intracellular dopamine content and [l]{.smallcaps}-DOPA-induced increases in dopamine content in PC12 cells ([Figure 2](#molecules-13-00475-f002){ref-type="fig"}A and [Figure 6](#molecules-13-00475-f006){ref-type="fig"}A). Both TH and AADC activities were inhibited by 0.05 μM anonaine: the inhibition of TH activity was stronger and longer than that of AADC activity ([Figure 3](#molecules-13-00475-f003){ref-type="fig"}). Anonaine also showed inhibitory trends of TH mRNA levels, but not significant ([Figure 4](#molecules-13-00475-f004){ref-type="fig"}). Anonaine decreased cyclic AMP levels at 10-60 min ([Figure 5](#molecules-13-00475-f005){ref-type="fig"}A), but not reduced basal Ca^2+^ concentration ([Figure 5](#molecules-13-00475-f005){ref-type="fig"}B).

![Effects of anonaine on cyclic AMP level (A) and Ca^2+^ concentration (B) in PC12 cells. PC12 cells were treated with anonaine (0.05 µM) and incubated at 37°C for 10 min. Intracellular cyclic AMP levels were measured by enzyme immunoassay kit. PC12 cells were also loaded with fura-2 AM for 10-60 min, and intracellular Ca^2+^concentration was assayed described under Materials and methods. Cyclic AMP levels of control were 241.6 ± 12.5 pmol/mg protein. Results represent means ± S.E.M. of 6-8 wells. Significantly different from control values: \*\*\*P\<0.001 (ANOVA followed by Tukey's test).](molecules-13-00475-g005){#molecules-13-00475-f005}

![Effects of anonaine on [l]{.smallcaps}-DOPA-induced dopamine content (A) and cytotoxicity (B) in PC12 cells. PC12 cells were exposed to [l]{.smallcaps}-DOPA (50 µM and 100 µM) in the absence or presence of anonaine (0.05 µM) for 24 h. Dopamine content and cell viability were determined by an HPLC system and MTT method as described under Materials and Methods. Results represent means ± S.E.M. of 6-8 dishes or wells. \*P\<0.05 compared to control values, \#P\<0.05 compared to the corresponding *L*-DOPA concentrations (ANOVA followed by Tukey's test).](molecules-13-00475-g006){#molecules-13-00475-f006}

The total decreased dopamine content by long term-treated anonaine (24-48 h) could not be affected by extracellular dopamine release at early time points (0.5-1 h) ([Figure 2](#molecules-13-00475-f002){ref-type="fig"}A, [Figure 2](#molecules-13-00475-f002){ref-type="fig"}B). These results suggest that anonaine can inhibit dopamine biosynthesis by mainly reducing TH activity in PC12 cells. It has been found that the cytotoxic action of [l]{.smallcaps}-DOPA is mediated by reactive oxygen species such as hydrogen peroxide, associated with oxygen free radicals and quinone derivatives \[[@B9-molecules-13-00475]\]. In our previously studies, 20-100 μM [l]{.smallcaps}-DOPA increases dopamine content after 24 h in PC12 cells \[[@B17-molecules-13-00475],[@B21-molecules-13-00475]\]. However, at concentrations higher than 50 μM for 48 h [l]{.smallcaps}-DOPA induces intracellular cytotoxicity by oxidative stress \[[@B17-molecules-13-00475],[@B27-molecules-13-00475]\]. Tetrahydropapaveroline and hydrastine also aggravate [l]{.smallcaps}-DOPA (50-100 μM)-induced cytotoxicity in PC12 cells \[[@B17-molecules-13-00475],[@B27-molecules-13-00475]\]. In contrast, phenolic aporphine alkaloids such as bulbocapnine and boldine exhibit anti-peroxidative and anti-oxidant effects \[[@B28-molecules-13-00475],[@B29-molecules-13-00475]\]. Boldine also decreases dopamine-induced death in PC12 cells \[[@B29-molecules-13-00475]\]. In addition, glaucine, the nonphenolic dimethyl ether of boldine, showed a potent anti-oxidant activity \[[@B14-molecules-13-00475]\]. In the present study, when [l]{.smallcaps}-DOPA (50-100 μM) was associated with anonaine (0.05 μM), the cell viability was slightly increased compared with [l]{.smallcaps}-DOPA alone ([Figure 6](#molecules-13-00475-f006){ref-type="fig"}B). However, anonaine could not show a significant protective activity against [l]{.smallcaps}-DOPA (50-100 μM)-induced cytotoxicity at 24-48 h in PC12 cells.

The order of inhibitory potency on dopamine biosynthesis was: anonaine \> liriodenine \> bulbocapnine, in comparison with their IC~50~ values (anonaine, 0.05 μM; liriodenine, 8.4 μM; bulbocapnine 26.7 μM) \[[@B10-molecules-13-00475],[@B11-molecules-13-00475]\]. Therefore, it is suggested that the isoquinoline ring planarity (liriodenine and anonaine) ([Figure 1](#molecules-13-00475-f001){ref-type="fig"}) and the 11-hydroxy and methoxy groups of the aporphine alkaloid structure (bulbocapnine) play a key role in the inhibition of dopamine biosynthesis in PC12 cells. Liriodenine, a very planar molecule ([Figure 1](#molecules-13-00475-f001){ref-type="fig"}, B), is a strong topoisomerase II inhibitor presenting DNA intercalation \[[@B30-molecules-13-00475]\]. However, bulbocapnine, which does not possess a planar conformation, is inactive as a topoisomerase II inhibitor and does not unwind DNA \[[@B30-molecules-13-00475]\]. Liriodenine reduced TH mRNA levels in PC12 cells \[[@B11-molecules-13-00475]\], however, bulbocapnine did not affect them \[[@B10-molecules-13-00475]\]. Therefore, it is proposed that a planar molecule anonaine might have a weak DNA-binding activity, which could not reduce TH mRNA levels significantly ([Figure 4](#molecules-13-00475-f004){ref-type="fig"}).

Conclusions
===========

In summary, anonaine inhibited dopamine biosynthesis by mainly reducing TH activity in PC12 cells. Anonaine also reduced [l]{.smallcaps}-DOPA-induced increases in dopamine content without aggravating [l]{.smallcaps}-DOPA-induced cell death. The in vivo pharmacological applications of anonaine need to be further studied.

Experimental
============

Materials
---------

Anonaine was supplied by the Korea Research Institute of Chemical Technology \[[@B31-molecules-13-00475]\]. 3-(4,5-Dimethyl-2-thiazolyl)-2,5-di-phenyl-2H-tetrazolium bromide (MTT), [l]{.smallcaps}-DOPA, [l]{.smallcaps}-tyrosine, [d]{.smallcaps}[l]{.smallcaps}-6-methyl-5,6,7,8-tetrahydropterine and Fura-2 AM were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Cyclic AMP enzyme immunoassay kit was purchased from Amersham Pharmacia Biotech (Little Chalfont, Buckinghamshire, UK). All sera, antibiotics and RPMI 1640 for cell culture were obtained from Gibco (Grand Island, NY, USA). All other chemicals were of reagent grade.

Cell culture
------------

PC12 cells were grown in RPMI medium 1640 supplemented with 10% heat-inactivated horse serum, 5% heat-inactivated fetal bovine serum, 100 units/mL penicillin and 100 μL/mL streptomycin. The cells were placed in a humidified atmosphere with 5% CO~2~ and 95% air at 37°C \[[@B15-molecules-13-00475]\].

Determination of dopamine content
---------------------------------

Intracellular and extracellular dopamine content was analyzed by HPLC \[[@B10-molecules-13-00475],[@B19-molecules-13-00475]\]. Briefly, trichloroacetic acid (1 M, 100 μL) and isoproterenol (150 pmol, internal standard) were added to the pellet extracts. The mixture was passed through a Toyopak SP-M cartridge (Na^+^, resin 1 mL, Toso, Tokyo, Japan). The cartridge eluate was derivatized with 1,2-diphenylethylenediamine and the final reaction mixture was injected into an HPLC system (Toso). The HPLC conditions were identical to those described previously \[[@B19-molecules-13-00475]\].

Assay for TH and AADC activities
--------------------------------

TH activity was measured according to a slight modification of the procedure of Nagatsu *et al*. \[[@B32-molecules-13-00475]\] as described previously \[[@B19-molecules-13-00475]\]. The amount of [l]{.smallcaps}-DOPA produced from the substrate [l]{.smallcaps}-tyrosine was determined using an HPLC equipped with a CM8010 electrochemical detector (Toso) as described previously \[[@B19-molecules-13-00475]\]. For the determination of AADC activity, the amount of dopamine formed from the substrate [l]{.smallcaps}-DOPA at 37°C for 10 min was also determined by HPLC \[[@B19-molecules-13-00475],[@B33-molecules-13-00475]\].

RNA extraction and Northern blotting
------------------------------------

Total RNA from PC12 cells was isolated and separated by electrophoresis on 1% agarose gel containing 0.66 M formaldehyde and transferred to a nylon membrane (ICN, East Hills, NY, USA) \[[@B34-molecules-13-00475]\]. The Northern blot analysis for TH mRNA was performed by hybridizing to the coding regions of the 0.7 kb rat TH cDNA probe labeled with \[α-^32^P\] dCTP \[[@B4-molecules-13-00475]\] using a Random Primer labeling system (DuPont NEN, Boston, MA, USA). Rat α-tubulin was used as an internal standard. After exposure of blots to X-ray film, the auto-radiographs were quantified by scanning laser densitometry (Ultra Scan XL, LKB, Bromma, Sweden).

Measurement of cyclic AMP levels
--------------------------------

The cyclic AMP levels in PC12 cells were measured using an enzyme immunoassay system kit. PC12 cells were incubated in 96-well plate overnight at 37°C. The cells were incubated for a suitable time and agitated after lysis reagent was added. Finally, the absorbance was determined using a Microplate Reader (Molecular Devices, CA, USA) at 450 nm.

Measurement of intracellular Ca^2+^ concentration
-------------------------------------------------

PC12 cells were harvested and washed with modified Krebs-Ringer-HEPES solution (pH adjusted to 7.4 with NaOH) \[[@B11-molecules-13-00475]\]. The cells were loaded with 5 μM Fura-2 AM at 37°C for 30-60 min and the fluorescence intensity was measured with a Luminescence Spectrometer (PTI, Photon Technology International Inc., USA, excitation wavelengths 340 nm and 380 nm, emission wavelength 510 nm).

Measurement of cell viability: MTT assay
----------------------------------------

The cell viability was performed by MTT assay \[[@B35-molecules-13-00475]\]. After PC12 cells were treated with the aporphine alkaloids, MTT solution (final concentration, 1 mg/mL) was added to each well and further incubated for 4 h at 37°C. The absorbance was then measured at 570 nm with a Bauty Diagnostic Microplate Reader (Molecular Devices, CA). Cell viability was expressed as a percentage of control value.

Statistical analysis
--------------------

All data were presented as means ± S.E.M. of at least four experiments. Protein amounts were determined using bovine serum albumin as a standard \[[@B36-molecules-13-00475]\]. Statistical analysis was performed by ANOVA followed by Tukey's test.
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